Ensoma shutters Copenhagen site from its Twelve Bio acquisition
Genomic medicines startup Ensoma is shuttering its Copenhagen site and also eliminating “a very small number” of roles at its Boston office, a spokesperson confirmed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.